Related Experiment Video
Updated: Nov 25, 2025

Detection of Polyfunctional T Cells in Children Vaccinated with Japanese Encephalitis Vaccine via the Flow Cytometry Technique
Published on: September 23, 2022
Enrolling Minors in COVID-19 Vaccine Trials
Kevin Mintz1, E Jardas1, Seema Shah2,3
1Department of Bioethics, National Institutes of Health, Bethesda, Maryland.
Abstract:
It is widely agreed that an effective response to the coronavirus disease 2019 pandemic needs to include a vaccine that is safe and effective for minors. However, many current vaccine trials have no plans for when to enroll minors. Others have recently proposed enrolling minors as young as 12 years old. This lack of a systematic approach raises 2 concerns. Waiting too long to enroll minors could unjustly deny minors and their families the benefits of a vaccine and has the potential to delay an effective response to the pandemic by a year or longer. At the same time, enrolling minors too soon runs the risk of exposing them to excessive risks. With these concerns in mind, in the present article, we propose recommendations for when and how to enroll minors in vaccine trials for the coronavirus disease 2019.
Related Concept Videos
Clinical Trials
There are four phases in a clinical trial. A phase one...
Vaccinations
Clinical Trials: Overview
Drug Dosing: Infants and Children
Bioavailability Study Design: Healthy Subjects Versus Patients
Bioequivalence studies: Biowaivers

